INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,568,223 | -73.5% | 28,024 | -75.5% | 0.01% | -73.5% |
| Q2 2022 | $5,921,499 | -47.3% | 114,403 | -26.1% | 0.05% | -31.0% |
| Q1 2022 | $11,245,392 | +5.5% | 154,746 | +71.7% | 0.07% | +14.5% |
| Q4 2021 | $10,656,025 | -28.9% | 90,122 | -19.3% | 0.06% | -43.6% |
| Q3 2021 | $14,990,055 | -30.8% | 111,741 | -16.4% | 0.11% | -19.1% |
| Q2 2021 | $21,647,367 | +122.1% | 133,700 | +10.1% | 0.14% | +58.1% |
| Q1 2021 | $9,747,211 | +646.6% | 121,453 | +406.1% | 0.09% | +681.8% |
| Q4 2020 | $1,305,600 | +406.0% | 24,000 | +84.6% | 0.01% | +266.7% |
| Q3 2020 | $258,000 | -64.2% | 13,000 | -73.6% | 0.00% | -50.0% |
| Q4 2019 | $721,000 | – | 49,175 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $12,567,735 | 6.39% |
| Casdin Capital, LLC | 2,000,000 | $44,760,000 | 3.43% |
| Deep Track Capital, LP | 4,800,000 | $107,424,000 | 3.21% |
| Contrarius Investment Management Ltd | 1,915,410 | $42,867 | 2.68% |
| ARK Investment Management | 11,595,789 | $259,513,759 | 2.30% |
| Capital Impact Advisors, LLC | 26,554 | $594,279 | 1.67% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,029,982 | $23,050,997 | 1.63% |
| MPM BioImpact LLC | 443,503 | $9,925,597 | 1.54% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 117,315 | $2,625,510 | 1.44% |
| Orchard Capital Management, LLC | 170,006 | $3,804,734 | 1.15% |